Cargando…
Treatment gains from the “sandwich method” of abiraterone acetate for men with metastatic prostate cancer: a case report and sharing of our experience
To date, how to select an appropriate strategy to treat advanced prostate cancer (PCa) patients with tumor progression after abiraterone acetate (AA) intervention is still confusing. Here, we conducted a case report and review of the literatures focused on this issue. A 63-year-old man presented ini...
Autores principales: | Wang, Hui, Li, Xin, Zhang, Ping, Liu, Shixiong, Xie, Qiang, Zhao, Shankun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354285/ https://www.ncbi.nlm.nih.gov/pubmed/32676430 http://dx.doi.org/10.21037/tau-19-851 |
Ejemplares similares
-
Phase II Trial of Abiraterone Acetate Plus Prednisone in Black Men With Metastatic Prostate Cancer
por: Tsao, Che-Kai, et al.
Publicado: (2016) -
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer
por: Chi, Kim N., et al.
Publicado: (2023) -
Abiraterone Acetate
Publicado: (2012) -
Abiraterone acetate in metastatic castration-resistant prostate cancer – the unanticipated real-world clinical experience
por: Poon, Darren M. C., et al.
Publicado: (2016) -
Abiraterone acetate for early stage metastatic prostate cancer: patient selection and special considerations
por: Castellan, Pietro, et al.
Publicado: (2018)